Trial Outcomes & Findings for Exercise Therapy Program in Ankylosing Spondylitis Patients (NCT NCT01690273)

NCT ID: NCT01690273

Last Updated: 2016-10-20

Results Overview

BASFI - Bath ankylosing spondylitis functional index. A scale from 0 to 10 (lower scores means better functional capacity), results are measured by mean and standard deviation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

55 participants

Primary outcome timeframe

Baseline and 16 Weeks

Results posted on

2016-10-20

Participant Flow

Two hundred nine consecutive patients from the division of rheumatology outpatient clinic of the university hospital (Clinics Hospital of University Medicine School of Sao Paulo) diagnosed with AS according to the modified New York criteria, were invited to participate. Fifty Five individuals were randomly allocated into three groups

Seventy patients did not accepted and 84 did not followed inclusion criteria. Fifty five were allocated into three groups after following the inclusion criteria.

Participant milestones

Participant milestones
Measure
Ankylosing Spondylitis Control
control group, no intervention in ankylosing spondylitis patients
Mobility in Ankylosing Spondylitis
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility and Elastic Resistance Exercise in AS
mobility, plus elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Overall Study
STARTED
18
17
20
Overall Study
COMPLETED
18
17
20
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Exercise Therapy Program in Ankylosing Spondylitis Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ankylosing Spondylitis Control
n=18 Participants
Following a randomization, patients from control group stays during sixteen weeks only with medical treatment.
Stretching in AS
n=17 Participants
stretching exercises stretching exercise: 30 minutes, twice a week for sixteen weeks.
Elastic Resistance Exercise in AS
n=20 Participants
stretching and elastic resistance exercises stretching and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour) for sixteen weeks.
Total
n=55 Participants
Total of all reporting groups
Age, Continuous
47.1 years
STANDARD_DEVIATION 10.8 • n=5 Participants
49.2 years
STANDARD_DEVIATION 13.1 • n=7 Participants
48.3 years
STANDARD_DEVIATION 11.1 • n=5 Participants
48.2 years
STANDARD_DEVIATION 11.7 • n=4 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
7 Participants
n=4 Participants
Sex: Female, Male
Male
15 Participants
n=5 Participants
15 Participants
n=7 Participants
18 Participants
n=5 Participants
48 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
White
13 Participants
n=5 Participants
12 Participants
n=7 Participants
13 Participants
n=5 Participants
38 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
5 Participants
n=5 Participants
5 Participants
n=7 Participants
7 Participants
n=5 Participants
17 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Baseline and 16 Weeks

BASFI - Bath ankylosing spondylitis functional index. A scale from 0 to 10 (lower scores means better functional capacity), results are measured by mean and standard deviation.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
FUNCTIONAL INDEX
baseline
3.4 units on a scale
Standard Deviation 2.7
4.3 units on a scale
Standard Deviation 1.9
3.2 units on a scale
Standard Deviation 2.6
FUNCTIONAL INDEX
16 weeks
4.5 units on a scale
Standard Deviation 2.5
4.0 units on a scale
Standard Deviation 2.2
2.2 units on a scale
Standard Deviation 2.0

PRIMARY outcome

Timeframe: Baseline and 16 weeks

Bath ankylosing spondylitis motion index. A mean of five mobility measures committed by Ankylosing Spondylitis disease. Higher results means higher limitations in mobility (units of measure from 0 to 10)

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Mobility Index
baseline
4.3 units on a scale from 0 to 10
Standard Deviation 2
5.3 units on a scale from 0 to 10
Standard Deviation 2
4.5 units on a scale from 0 to 10
Standard Deviation 2.1
Mobility Index
16 weeks
4.6 units on a scale from 0 to 10
Standard Deviation 2.0
4.8 units on a scale from 0 to 10
Standard Deviation 2.1
4.0 units on a scale from 0 to 10
Standard Deviation 2.1

PRIMARY outcome

Timeframe: Baseline and 16 Weeks

BASDAI - Bath ankylosing spondylitis disease activity index. Scale from 0 to 6. Higher scores means worst disease activity. Numbers are expressed in average (SD)

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Disease Activity Index
baseline
2 units on a scale
Standard Deviation 1
2.6 units on a scale
Standard Deviation 1.1
2.1 units on a scale
Standard Deviation 1.4
Disease Activity Index
16 weeks
3.2 units on a scale
Standard Deviation 2.0
2.9 units on a scale
Standard Deviation 1.4
1.7 units on a scale
Standard Deviation 1.4

PRIMARY outcome

Timeframe: Baseline and 16 Weeks

Scores vary from 0 to 10, and higher than 4 scores are indicative of disease activity. Data are expressed by means and SD

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Ankylosing Spondylitis Disease Activity Scale -Disease Activity
baseline
1.8 units on a scale
Standard Deviation 0.7
1.7 units on a scale
Standard Deviation 0.7
1.5 units on a scale
Standard Deviation 0.7
Ankylosing Spondylitis Disease Activity Scale -Disease Activity
16 weeks
2.2 units on a scale
Standard Deviation 0.8
1.6 units on a scale
Standard Deviation 0.7
1.4 units on a scale
Standard Deviation 0.7

PRIMARY outcome

Timeframe: Baseline and 16 Weeks

Bath Ankylosing Spondylitis Global is a self reported global score varying from 0 to 10. Higher scores means worst health evaluation. Expressed by means and standard deviation.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Global Evaluation Self Reported
baseline
3.6 units on a scale
Standard Deviation 1.9
5.0 units on a scale
Standard Deviation 2.3
4.1 units on a scale
Standard Deviation 2.6
Global Evaluation Self Reported
16 weeks
5.6 units on a scale
Standard Deviation 2.4
4.7 units on a scale
Standard Deviation 2.2
3.4 units on a scale
Standard Deviation 2.5

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Thoracolumbar rotation Pavelka. Measured with a tape in centimeters. Higher number means better thoracolumbar rotation

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Thoracolumbar Mobility
baseline
1.9 Centimeters
Standard Deviation 1.5
1.4 Centimeters
Standard Deviation 0.9
1.6 Centimeters
Standard Deviation 1.1
Thoracolumbar Mobility
16 weeks
1.7 Centimeters
Standard Deviation 0.9
2.1 Centimeters
Standard Deviation 1.0
2.6 Centimeters
Standard Deviation 1.1

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Pain was evaluated in a visual analogue scale (VAS) from 0 to 10. higher scores means much pain. Data was expressed by means and standard deviation.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Pain Scale
baseline
1.8 units on a scale
Standard Deviation 1.8
2.5 units on a scale
Standard Deviation 1.9
2.0 units on a scale
Standard Deviation 1.9
Pain Scale
16 weeks
2.3 units on a scale
Standard Deviation 2.7
2.4 units on a scale
Standard Deviation 1.5
2.0 units on a scale
Standard Deviation 1.9

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Stiffness was measured by an VAS varying from 0 to 10. Higher scores means worst stiffness. Data are expressed by mean and SD.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Stiffness Scale
baseline
3.1 units on a scale
Standard Deviation 2.6
3.1 units on a scale
Standard Deviation 2.2
3.1 units on a scale
Standard Deviation 2.4
Stiffness Scale
16 weeks
4.3 units on a scale
Standard Deviation 2.6
4.2 units on a scale
Standard Deviation 2.0
2.8 units on a scale
Standard Deviation 2.0

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Quality of life was analyzed in a physical component score varying from 0 (lowest level of health) to 100 (highest level of health) scale. Data are expressed by mean and SD.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Short Form-12 (PCS)
baseline
42.3 units on a scale
Standard Deviation 7.4
38.8 units on a scale
Standard Deviation 8.0
43.9 units on a scale
Standard Deviation 8.5
Short Form-12 (PCS)
16 weeks
41.9 units on a scale
Standard Deviation 8.8
40.9 units on a scale
Standard Deviation 10.6
44.8 units on a scale
Standard Deviation 8.8

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Quality of life was analyzed in a mental component score varying from 0 (lowest level of health) to 100 (highest level of health). Data are expressed by mean and SD.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Short Form-12 (MCS)
baseline
51.8 units on a scale
Standard Deviation 10.7
45.7 units on a scale
Standard Deviation 11.6
47.1 units on a scale
Standard Deviation 13.5
Short Form-12 (MCS)
16 weeks
52.1 units on a scale
Standard Deviation 9.7
46.0 units on a scale
Standard Deviation 10.8
51.6 units on a scale
Standard Deviation 12.4

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) score varying from 0 to 13. Where 0 is no painful point reported and 13 is all tender points reported as painful. Data are expressed by means and standard deviation

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
MASES
baseline
0.7 Number of painful tender points
Standard Deviation 1.4
1.5 Number of painful tender points
Standard Deviation 3.4
0.8 Number of painful tender points
Standard Deviation 1.7
MASES
16 weeks
1.3 Number of painful tender points
Standard Deviation 1.9
1.1 Number of painful tender points
Standard Deviation 1.7
0.7 Number of painful tender points
Standard Deviation 1.5

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

lateral rotation of the head (chin-coronoid distance) was measured with a tape in centimeters. Highest score means better lateral rotation mobility. Data are expressed by means and standard deviation

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Chin-coronoid Distance
baseline
9.9 Centimeters
Standard Deviation 2.7
14.2 Centimeters
Standard Deviation 5.6
10.9 Centimeters
Standard Deviation 3.6
Chin-coronoid Distance
16 weeks
10.0 Centimeters
Standard Deviation 2.5
9.5 Centimeters
Standard Deviation 2.3
9.2 Centimeters
Standard Deviation 1.6

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

lateral flexion of the head (tragus-coronoid distance) was measured with a tape in centimeters. Highest score means better lateral flexion mobility of the head.Data are expressed by means and standard deviation

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Tragus-coronoid Distance
baseline
9.9 Centimeters
Standard Deviation 2.7
12.3 Centimeters
Standard Deviation 4.0
9.7 Centimeters
Standard Deviation 3.3
Tragus-coronoid Distance
16 weeks
10.1 Centimeters
Standard Deviation 2.2
9.0 Centimeters
Standard Deviation 2.0
8.8 Centimeters
Standard Deviation 2.0

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Distance between third finger of the hand and the floor while in lumbar flexion. It was measured with a tape in centimeters. Highest score means better torso flexion mobility. Data are expressed by means and standard deviation

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Finger Floor Distance
baseline
27.6 Centimeters
Standard Deviation 13.3
27.1 Centimeters
Standard Deviation 13.7
23.7 Centimeters
Standard Deviation 12.0
Finger Floor Distance
16 weeks
29.5 Centimeters
Standard Deviation 13.6
24.2 Centimeters
Standard Deviation 13.3
20.3 Centimeters
Standard Deviation 11.8

SECONDARY outcome

Timeframe: Baseline and 16 Weeks

Chest expansion was measured with a tape in centimeters between inspiration and breathing exhaling. Highest score means better chest expansion. Data are expressed by means and standard deviation.

Outcome measures

Outcome measures
Measure
Ankylosing Spondylitis Control
n=18 Participants
control group with AS patients and no exercise
Mobility in AS
n=17 Participants
mobility exercises mobility exercise: 30 minutes, twice a week
Mobility Plus Elastic Resistance Exercise in AS
n=20 Participants
mobility and elastic resistance exercises mobility and elastic resistance exercise: 30 minutes, twice a week each exercises group. (total 1 hour)
Chest Expansion
baseline
2.8 Centimeters
Standard Deviation 1.3
2.8 Centimeters
Standard Deviation 1.2
3.6 Centimeters
Standard Deviation 1.7
Chest Expansion
16 weeks
3.0 Centimeters
Standard Deviation 1.9
3.3 Centimeters
Standard Deviation 1.2
4.3 Centimeters
Standard Deviation 1.9

Adverse Events

Ankylosing Spondylitis Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Stretching in AS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Elastic Resistance Exercise in AS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Andrea Lopes Gallinaro; Researcher

Universidade Sao Paulo

Phone: 55112601

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place